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The MHC-encoded class II or Ia antigens are highly polymorphic glycoproteins 
consisting of  a heterodimeric structure with an o~ subunit of 33-36,000 kD and 
a 8 subunit of  24-28,000 kD (1). They play an important role in the homeostasis 
of  the immune system (2). 
In man there are at least three class II genetic subregions designated DP, DQ, 
DR, each encoding distinct a//3 heterodimers (1, 3, 4). 
Control of Ia antigen expression at the cell surface, in addition to polymor- 
phism and heterogeneity, influences the role of class II antigens in the regulation 
of the immune response (5). 
We recently described a human B cell variant, RJ 2.2.5, derived from Raji 
cells after mutagenesis and immunoselection with anti-Ia mAb (6). The  RJ 2.2.5 
cells express none of  the class II antigens (6), as shown by a lack of  specific class 
II mRNAs (7, 8). The  class I I-positive phenotype of RJ 2.2.5 cells can be restored 
in somatic cell hybrids between this variant and mouse B lymphoma cells (8) or 
mouse spleen cells (9). Phenotypic and structural studies have indicated that in 
these hybrids a mouse factor, unlinked to MHC products, is acting as an activator 
that positively regulates the expression of both mouse and man class II genes (9). 
Karyotypic analysis and segregation studies in an informative family of hybrids 
have now permitted us to assign the locus of  this trans-acting activator for class 
II genes to mouse chromosome 16. 
Mater ials and Methods  
Somatic Cell Hybrids. In previous reports, we have described the derivation of the RJ 
2.2.5 Ia- variant (6) and of RJ 2.2.5 x mouse spleen cell hybrids (9) used in this study. 
Selection of the hybrids on the basis of the presence or absence of a relevant MHC antigen 
on the cell surface was carried out on a FACS II (Becton Dickinson Immunocytometry 
Systems, Mountain View, Ca) after indirect immunofluorescence staining of the cells with 
specific mAbs (see legend to Fig. 1), as reported (9). 
Karyotype Analysis. The karyotype of the various cell lines described in this study was 
analyzed after metaphase chromosome preparation and staining by G-banding following 
standard procedures. 
DNA Analysis. Genomic DNA from the various cell lines was extracted as described 
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previously (8). After digestion with Hind III, the DNA was separated on a 0.7% agarose 
gel, transferred toGene Screen Plus hybridization transfer membranes (Amersham Corp., 
Buckinghamshire, United Kingdom), and hybridized with an c~-[32p]dNTP-labeled mouse 
Vkl probe, pc Vkl, derived from the genomic VM clone described in reference ! 1, and 
kindly donated by Dr. S. Weiss (Basel Institute for hnmunology, Switzerland). The filters 
were washed in stringent conditions according to the specification of the manufacturers, 
and they were exposed to X-OMAT Kodak films for 10 d at -80°C. 
Results and Discussion 
To assign the locus encoding the trans-acting factor (activator of immune 
response genes-locus 1 lair-l]) to a specific mouse chromosome we selected a
series of RJ 2.2.5 × mouse spleen cell hybrids (9) with specified phenotypic 
characteristics. In one clone, designated A2-2.4 c.6 (similar to clone c.9 in 
reference 9), human HLA class I (A,B,C) antigens were expressed in 100% of 
the cells; human class II antigens of the DR subset were expressed in 90% of the 
cells. In a second class II subset, the DQ antigen was expressed in 87% of the 
cells (data not shown). Mouse H-2 class I (H-2K) and class II (I-A) antigens were 
expressed in 50% of the cells (see Fig. 1A). 
A2-2.4 c.6 cells had a modal chromosome number of 93-94. A pseudotetra- 
ploidy of the human genome was found, with a number of chromosomes ranging 
between 91 and 93. The parental RJ 2.2.5 human Ia- cells presented a chro- 
mosome number of 46, with various chromosome abnormalities including t(8; 14) 
and trisomy 7 (data not shown), frequently found in human Burkitt lymphoma 
lines (10). The human pseudotetraploidy of A2.2-4 c.6 probably arose by an 
accidental tri-parental mating, as suggested by the fact that all clones derived 
from the hybrid A2 exhibited similar human chromosome complement. Analysis 
of a large number of metaphases of A2-2.4 c.6 cells (see Fig. 1) revealed the 
presence of two mouse chromosomes, namely the 17 and a second chromosome, 
which by cytogenetic haracteristics was identical to mouse chromosome 16 
except for a small deletion of part of its distal region (band C3 and probably part 
of C2 and C4) (see Fig. 1 B, top). The assignment was confirmed by Southern 
blot hybridization with a probe specific for the V3,1 Ig gene (11) located on 
mouse chromosome 16 (12, see below). Karyotyping of A2-2.4 c.6 cells showed 
that mouse chromosome 17 was present in 50% of the metaphases analyzed, in 
agreement with the proportion of cells actually displaying mouse MHC class I 
antigens on the cell surface. Mouse chromosome 16 was found in 86% of the 
metapbases analyzed, in agreement with the proportion of cells reexpressing 
human class II antigens in the clone hybrid. These results suggested that the 
presence of mouse chromosome 16 correlated with the presence of the class II 
gene-activator trans-acting factor. To better demonstrate his point, we used the 
FACS to separate the A2-2.4 c.6 population into two fractions on the basis of a 
DR + and DR- phenotype, respectively. The cells from each fraction were first 
expanded by in vitro culture and then karyotyped. The results of such analysis 
are reported in Fig. 1. At the time of karyotyping the DR+-selected cells expressed 
the following cell surface MHC phenotypes: HLA, A,B,C, 100%; DR, 91%; H- 
2K, 23%; I-A, 25%. Accordingly, mouse chromosome 16 was present in 92% 
and mouse chromosome 17 in 24% of the metaphases analyzed. DR--selected 
cells expressed the following cell surface MHC phenotypes: HLA A,B,C, 100%; 
DR, 2%; H-2K, 13%. Accordingly, mouse chromosome 16 was present in 3% 
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FIGURE 1. (A) MHC phenotype and corresponding mouse chromosomes found i  informa- 
tive RJ 2.2.5 x mouse spleen cell hybrids. The MHC phenotype of the hybrids listed on the 
top of each panel was assessed by indirect immunofluorescence with specific mAbs and FACS. 
(a) HLA-A,B,C (mAb B9.12.1 [14]); (b) DR (mAb Dl -12 [3]); (c) H-2K (mAb S13.11 [15]); 
(d) I-A (mAb 25.9.17 [16]). Results are expressed as percent positive cells (ordinate). For each 
hybrid 40-60 metaphases were analyzed and the number of metaphases with the specific 
mouse chromosomes (16, 17, and 3) listed on the abscissa was expressed as percent of the total 
number analyzed (ordinate). (B) Aspect of metaphase mouse chromosomes 16, 17, and 3 (G- 
banding) as found in the various hybrids analyzed in this study. When present (see A), the 
chromosome 16 in A2-derived hybrids (upper panel) presented a small deletion (arrow) of the 
distal region (band C3, and probably part of C2 and C4), in contrast to the canonic hromosome 
16 found in H4-derived hybrids (lower panel). A schematic representation f mouse chromo- 
some 16 is also reported in both panels for comparison. 
and mouse chromosome 17 in 11% of the metaphases analyzed. These results 
were further corroborated by DNA analysis of the two distinct hybrid popula- 
tions. Hybridization with the mouse V?,I probe was clearly positive with the 
DR+-selected cells (Fig. 2b), whereas no hybridization was observed with the 
DR--selected cells (Fig. 2c). Therefore, segregation of mouse chromosome 16 
was accompanied by the loss of reexpressibility of human class I! genes in the 
A2-2.4 c.6 hybrid. 
The association of mouse chromosome 16 with the reexpressibility of the 
human class II genes was further documented by the analysis of two other clones, 
one of which, A2-KD, was derived from the same original A2 hybrid (9) after 
selection for H-2K + cells and further cloning by limiting dilution technique; the 
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FIGURE 2. Presence of a mouse chromosome 16 marker in various hybrids and parental cell 
lines as detected by Southern blot hybridization with an Ig VM probe. (a) RJ 2.2.5 DNA; (b) 
DNA from a FACS-enriched DR + population from A2-2.4 c.6 presenting chromosome 16 in 
its karyotype; (c) DNA from a FACS-enriched DR- population from A2-2.4 c.6 not containing 
chromosome 16 in its karyotype; (d) DNA from A2-KD, a DR- derivative of A2; (e) DNA 
from M 12,4.1, a mouse B cell lymphoma line. 
second clone, designated H4, originated from a distinct hybrid selected early 
after fusion of RJ 2.2.5 and mouse spleen cells. Interestingly, the A2-KD clone 
did not express either human or mouse class II gene products, although uman 
class I was expressed in 100% of the cells and mouse H-2K in 74% of the cells 
(Fig. 1 a). 
Karyotype analysis of A2-KD clone revealed the presence of a single mouse 
chromosome, namely chromosome 17 (Fig. 1, A and B), in 76% of the cells; it 
also revealed the pseudotetraploidy of human chromosomes already observed 
for the A2-2.4 c.6 hybrid cells. As expected, Southern blot hybridization exper- 
iments revealed no hybridization of the probe containing the V~I gene with 
DNA prepared from A2-KD cloned cells (Fig. 2 d). 
The second hybrid, namely H4, displayed an MHC cell surface phenotype 
consisting of: HLA-A,B,C, 100%; DR, 42%; H-2K, 1%; I-A, 1% (data not shown). 
As for A2.2-4 c.6 hybrid, H4 cells were selected with e FACS on the basis of 
DR + and DR- phenotype, and then karyotyped. Interestingly, both H4 popula- 
tions had the same human ploidy as RJ 2.2.5 cells (46 chromosomes, data not 
shown). Two mouse chromosomes were detectable by karyotyping, the 16 and 
the 3 (Fig. 1, A and B, bottom). In contrast o A2-derived hybrids, a canonic 
mouse chromosome 16 was present in the H4 hybrid. The presence of mouse 
chromosome 3 correlated with the ouabain-resistance selection (13) originally 
adopted to select for hybrids after RJ 2.2.5 × mouse spleen cell fusion (9). In 
the DR + (85%) population, chromosome 16 was present in 89% and chromosome 
3 in 70% of the metaphases analyzed. In the DR- population, chromosome 16 
was never found, whereas chromosome 3 was found in 30% of the metaphases 
analyzed (Fig. 1A). These results confirmed the exclusive association of the 
human Ia + phenotype with the presence of mouse chromosome 16. 
Taken together, the results presented in this report show that the presence of 
a single copy of mouse chromosome 16 in RJ 2.2.5 x mouse spleen cell hybrids 
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is a necessary and sufficient condition to allow expression of both mouse and 
human class II genes. We establish the existence of a newly found locus, air-l, 
that is located in this chromosome and determines a trans-acting activator 
function. Within this frame, the class II-negative phenotype in RJ 2.2.5 cells 
may thus be interpreted as originating from a lesion in the human equivalent of 
the air-1 locus coding for, or affecting the expression of, the trans-acting 
regulatory factor. 
The fact that a recessive lesion in a seemingly autosomal locus could be 
expressed in RJ 2.2.5 cells suggests either that these cells carry a double mutation 
at the alr-I locus-equivalent or that only one allele of this regulatory gene is 
normally functional in B cells. In the latter case, the other copy of the gene 
might be kept silent by allelic exclusion or a similar mechanism. In the former 
case, the two mutations could be cogenerated at the same time when Raji cells 
were mutagenized to obtain the RJ 2.2.5 variant (6), or alternatively, Raft cells 
used for mutagenesis could contain only one functional copy of the regulatory 
locus because of a previous independent mutational event that removed or 
inactivated one of the two alleles. The occurrence of chromosomal rearrange- 
ments in Burkitt lymphomas (10) may have some bearing on this point. The 
possibility that a gene dosage mechanism ay be responsible for the phenotype 
of RJ 2.2.5 cells seems less likely in view of the fact that, as proven by karyotype 
analysis, one copy of chromosome 16 was sufficient to allow reexpression ofboth 
mouse and human class II genes. 
The discovery of the alr-1 locus and its assignment to mouse chromosome 16 
will stimulate further efforts to isolate and clone the corresponding gene. This 
will in turn permit a biochemical characterization f the gene product and a 
detailed analysis of its mode of action. Moreover, the assessment of the role of 
this trans-acting factor in the developmental regulation of the expression of class 
II genes and of its influence on the functions mediated by class II gene products 
will be greatly facilitated. 
Summary 
RJ 2.2.5 is a human B cell line that has lost the capacity to express MHC class 
II genes. The human class II-positive phenotype is restored in somatic cell 
hybrids between RJ 2.2.5 and mouse spleen cells. 
By karyotype and molecular studies of an informative family of hybrids we 
have now shown that the reexpression of human class II gene products, as well 
as the maintenance of the mouse class II-positive phenotype, correlates with the 
presence of mouse chromosome 1(5. Thus, the existence on this mouse chromo- 
some of a newly found locus, designated by us Mr-l, that determines a trans- 
acting activator function for class II gene expression, is established. Possible 
implications of this finding are discussed. 
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